ORIONIS

What this means for you

This application is over — abandoned 29 Jan 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

88760741

Mark type

Stylized text

Filed

15 Jan 2020

Abandoned

29 Jan 2024

Attorney of record

Rachelle A. Dubow, Esq.

Goods and services

• Class 001 — Chemicals: Diagnostic, biological and chemical reagents for scientific and research use; pharmaceutical intermediates for use in the further manufacture of pharmaceuticals; Active chemical or biological ingredients for use in the manufacture of pharmaceuticals for treating cancer, auto immune diseases, metabolic diseases, neurological diseases, neuromuscular diseases
• Class 005 — Pharmaceuticals: Pharmaceutical products, serums and preparations for the treatment of cancer, auto immune disorders, metabolic disorders, neurological disorders, neuromuscular disorder; cytokines, namely, reagents for scientific and research use; pharmaceutical preparations, namely, cytokine inhibitory drugs; Therapeutic pharmaceutical and diagnostic preparations, namely, antibodies, cytokines, antigens, enzymes, immunoconjugates for treatment of cancer, immunological conditions, metabolic disorders; Biochemical and small molecule preparations for medical purposes for use in the treatment of cancer, auto immune diseases, metabolic diseases, neurological diseases, neuromuscular diseases
• Class 042 — Scientific and technological services: Development of new technology for others in the field of biotechnology; scientific research and laboratory research services in the medical, bacteriological and biotechnical fields; biotechnical research; technical consultation and research in the field of biotechnological research; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; research and development of pharmaceuticals for others; scientific and medical research in the fields of oncology, immunology and immune-oncology, inflammation, immune-mediated diseases, protein homeostasis, epigenetics and protein metabolism

Owner

• Orionis Biosciences Inc., Waltham, MA, US

Prosecution history

• 12 Feb 2024 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
• 12 Feb 2024 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
• 27 Oct 2023 — NOTIFICATION OF FINAL REFUSAL EMAILED
• 27 Oct 2023 — FINAL REFUSAL E-MAILED
• 27 Oct 2023 — FINAL REFUSAL WRITTEN
• 27 Sept 2023 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
• 31 Jan 2023 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
• 01 Jun 2022 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
• 29 Oct 2021 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
• 23 Apr 2021 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
• 10 Aug 2020 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
• 10 Aug 2020 — LETTER OF SUSPENSION E-MAILED
• 10 Aug 2020 — SUSPENSION LETTER WRITTEN
• 20 Jul 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 20 Jul 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE